What does DR. E. WYFFELS do?

DR. E. WYFFELS is a specialist medical practice in Asse. Private Limited, started on 4 February 2003, 1 establishment.

What is the address of DR. E. WYFFELS?

The registered office of DR. E. WYFFELS is located at Pullewouwe 86, 1730 Asse.

Is DR. E. WYFFELS still active?

Yes. According to the CBE (29 October 2026) DR. E. WYFFELS is active, legal situation “Normale toestand”, started on 4 February 2003.

Is DR. E. WYFFELS registered on Peppol?

Yes, DR. E. WYFFELS is registered on the Peppol network with ID 0208:0479461694.

What is the enterprise number of DR. E. WYFFELS?

The enterprise number of DR. E. WYFFELS is BE0479461694.

When was DR. E. WYFFELS founded?

DR. E. WYFFELS was founded on 4 February 2003.

Who are the directors of DR. E. WYFFELS?

According to the 2025 annual accounts, the directors of DR. E. WYFFELS are: Eric Wyffels.

Is DR. E. WYFFELS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 February 2003; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. E. WYFFELS make in 2025?

DR. E. WYFFELS posted a profit after taxes of € 298,034 in financial year 2025.

What is the revenue of DR. E. WYFFELS?

As a small company, DR. E. WYFFELS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 476,291.

DR. E. WYFFELS (Private Limited) - Asse - BE0479461694

Dossier DR. E. WYFFELS, printed on 29 October 2026 from databakkes.be/en/0479461694/dr-e-wyffels. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. E. WYFFELS from Asse, company number BE0479461694, closed financial year 2025 with a result of € 298,034 after tax. For that financial year DR. E. WYFFELS recorded a gross margin of € 476,291 and equity of € 1.4 million. Compared with financial year 2024, the result moved from € 259,965 to € 298,034. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.

What it is worth Growing

€ 1.4 million

▲ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 298,034

▲ 15% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1 million

▲ € 799,092 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 143,398 paid out

48 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 285,595

▲ 51% vs 2024

Of which on lease € 147,295.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 137,438

€ 27,610 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Taxes

€ 24,901

▲ € 24,151 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 366,476 Gross margin 2022: € 366,476 First fiscal year in the series	€ 408,208 Gross margin 2023: € 408,208 ▲ 11% vs 2022 (€ 366,476) Favourable step	€ 402,162 Gross margin 2024: € 402,162 ▼ 1% vs 2023 (€ 408,208) Unfavourable step	€ 476,291 Gross margin 2025: € 476,291 ▲ 18% vs 2024 (€ 402,162) Favourable step	▲ 18%
Profit after taxes	€ 216,565 Profit after taxes 2022: € 216,565 First fiscal year in the series	€ 257,249 Profit after taxes 2023: € 257,249 ▲ 19% vs 2022 (€ 216,565) Favourable step	€ 259,965 Profit after taxes 2024: € 259,965 ▲ 1% vs 2023 (€ 257,249) Favourable step	€ 298,034 Profit after taxes 2025: € 298,034 ▲ 15% vs 2024 (€ 259,965) Favourable step	▲ 15%
Equity	€ 1,018,748 Equity 2022: € 1,018,748 First fiscal year in the series	€ 1,184,711 Equity 2023: € 1,184,711 ▲ 16% vs 2022 (€ 1,018,748) Favourable step	€ 1,227,997 Equity 2024: € 1,227,997 ▲ 4% vs 2023 (€ 1,184,711) Favourable step	€ 1,382,632 Equity 2025: € 1,382,632 ▲ 13% vs 2024 (€ 1,227,997) Favourable step	▲ 13%
Total debts	€ 55,843 Total debts 2022: € 55,843 First fiscal year in the series	€ 56,280 Total debts 2023: € 56,280 ▲ 1% vs 2022 (€ 55,843) Unfavourable step	€ 2,339 Total debts 2024: € 2,339 ▼ 96% vs 2023 (€ 56,280) Favourable step	€ 162,339 Total debts 2025: € 162,339 ▲ € 159,999 vs 2024 (€ 2,339) Unfavourable step	▲ € 159,999
Cash	€ 440,265 Cash 2022: € 440,265 First fiscal year in the series	€ 167,643 Cash 2023: € 167,643 ▼ 62% vs 2022 (€ 440,265) Unfavourable step	€ 212,192 Cash 2024: € 212,192 ▲ 27% vs 2023 (€ 167,643) Favourable step	€ 1,011,284 Cash 2025: € 1,011,284 ▲ € 799,092 vs 2024 (€ 212,192) Favourable step	▲ € 799,092
Land & buildings	€ 6,247 Land & buildings 2022: € 6,247 First fiscal year in the series	€ 6,046 Land & buildings 2023: € 6,046 ▼ 3% vs 2022 (€ 6,247) Unchanged	€ 5,760 Land & buildings 2024: € 5,760 ▼ 5% vs 2023 (€ 6,046) Unchanged	€ 5,433 Land & buildings 2025: € 5,433 ▼ 6% vs 2024 (€ 5,760) Unchanged	▼ 6%
Retained profit	€ 1,000,148 Retained profit 2022: € 1,000,148 First fiscal year in the series	€ 1,166,111 Retained profit 2023: € 1,166,111 ▲ 17% vs 2022 (€ 1,000,148) Favourable step	€ 1,227,997 Retained profit 2024: € 1,227,997 ▲ 5% vs 2023 (€ 1,166,111) Favourable step	€ 1,382,632 Retained profit 2025: € 1,382,632 ▲ 13% vs 2024 (€ 1,227,997) Favourable step	▲ 13%
Dividend	€ 150,128 Dividend 2022: € 150,128 First fiscal year in the series	€ 91,286 Dividend 2023: € 91,286 ▼ 39% vs 2022 (€ 150,128) Unchanged	€ 198,080 Dividend 2024: € 198,080 ▲ 117% vs 2023 (€ 91,286) Unchanged	€ 143,398 Dividend 2025: € 143,398 ▼ 28% vs 2024 (€ 198,080) Unchanged	▼ 28%
Bank debt	€ 418 Bank debt 2022: € 418 First fiscal year in the series	€ 1,178 Bank debt 2023: € 1,178 ▲ 182% vs 2022 (€ 418) Unfavourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 1,178) Favourable step	€ 137,438 Bank debt 2025: € 137,438 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 1,074,592 Balance sheet total 2022: € 1,074,592 First fiscal year in the series	€ 1,240,991 Balance sheet total 2023: € 1,240,991 ▲ 15% vs 2022 (€ 1,074,592) Unchanged	€ 1,230,336 Balance sheet total 2024: € 1,230,336 ▼ 1% vs 2023 (€ 1,240,991) Unchanged	€ 1,544,971 Balance sheet total 2025: € 1,544,971 ▲ 26% vs 2024 (€ 1,230,336) Unchanged	▲ 26%

Key figures of DR. E. WYFFELS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. E. WYFFELS?

What happened at DR. E. WYFFELS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 14, 2026 New annual accounts for financial year 2025: profit of € 298,034 (▲ 15% vs 2024). Source: NBB ↗
2003 Eric Wyffels became a director. NBB
Feb 4, 2003 Start of the company according to the CBE. KBO
Jan 21, 2003 New establishment in Asse. KBO

In short

From € 216,565 profit in 2022 to € 298,034 profit in 2025.

Paid € 467,583 in corporate taxes since 2022.

Best year ever: 2025, with € 298,034 profit.

Paid out € 582,892 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Eric Wyffels

DR. E. WYFFELS

Cardiovascular Research Center Aalst

Behind DR. E. WYFFELS is Eric Wyffels. Eric Wyffels is also behind Cardiovascular Research Center Aalst.

Directors

According to the 2025 annual accounts

Eric Wyffels

Director

Also active at: Cardiovascular Research Center Aalst

since 2003

Establishments

Establishment units

Physical locations of this company

Registered office

Pullewouwe 86

1730 Asse

2.208.804.420

Bloklaan 5

1730 Asse

Active since 21 January 2003

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0479.461.694
VAT number: BE 0479.461.694
Registered office: Pullewouwe 86, 1730 Asse
Names & denominations: DR. E. WYFFELS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 February 2003
Peppol: Active · Active since 22 Apr 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗